Literature DB >> 11408007

The comparison of the ability of monoclonal antibodies directed to different proteins (human IgG, human myoglobin and HRP) and bispecific antibodies derived thereof to bind antigens immobilized on a surface of a solid phase.

D A Dmitriev1, Y S Massino, O L Segal, M B Smirnova, G I Kolyaskina, E V Pavlova, A P Osipov, A M Egorov, A D Dmitriev.   

Abstract

BACKGROUND: Bindings of mouse monoclonal antibodies (mAbs) and affinity purified bispecific antibodies (bAbs), derived thereof, to antigens adsorbed on immunoplates have been compared, using ELISA and RIA methods.
METHODS: The analysed panel of antibodies included mAbs specific to human myoglobin (Mb), human IgG (hIgG) and horseradish peroxidase (HRP) and biologically produced bAbs with double specificity to Mb and HRP, and to hIgG and HRP.
RESULTS: The degree of difference between different mAbs and corresponding bAbs varied markedly from antibody to antibody, depending on whether the parental mAbs could bind immobilized antigens bivalently. The observed equilibrium binding constant (K(obs)) for anti-HRP mAbs was 21-38 times higher that of anti-HRP site of bAbs (anti-hIgG/HRP or anti-Mb/HRP, respectively), due to bivalent binding of mAbs. Anti-Mb mAbs also bound bivalently with immobilized Mb. On the contrary, anti-hIgG mAbs bound monovalently with immobilized hIgG in the same conditions. The avidity of anti-Mb/HRP bAbs increased, if both antigens were simultaneously adsorbed on a solid phase.
CONCLUSIONS: The obtained data indicate that the use of bAbs in heterogeneous immunoassays instead of traditional mAb-enzyme conjugates hardly can provide the significant gain in assay performance if parental mAbs bind bivalently.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408007     DOI: 10.1016/s0009-8981(01)00531-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector.

Authors:  Thomas Hofer; Wisit Tangkeangsirisin; Michael G Kennedy; Rose G Mage; Stephen J Raiker; Karthik Venkatesh; Hakjoo Lee; Roman J Giger; Christoph Rader
Journal:  J Immunol Methods       Date:  2006-11-07       Impact factor: 2.303

2.  A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.

Authors:  Andrea Zito; Carla Bromuro; Giorgia Mandili; Paola Chiani; Alberto L Horenstein; Fabio Malavasi; Roberto Cauda; Antonio Cassone; Antonella Torosantucci
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.